Data / Form D filings / Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc.: Form D filings
Allarity Therapeutics, Inc., a biotechnology company in Boston, MA, filed 6 Form D notices with the SEC between 2021 and 2024. The latest, on February 2, 2024, reports $400,000 sold of a $1.4 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 24 SCHOOL ST., 2ND FLOOR, Boston, MA, 02108
- Phone
- (401) 426-4664
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1860657
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 2, 2024 | New notice | $1,400,000 | $400,000 | $1,000,000 | 1 | Jan 18, 2024 | sec.gov |
| Sep 21, 2023 | New notice | Indefinite | $1,601,578 | 2 | Sep 18, 2023 | sec.gov | |
| Apr 28, 2023 | New notice | $350,000 | $350,000 | 1 | Apr 21, 2023 | sec.gov | |
| Apr 28, 2023 | New notice | Indefinite | $3,366,640 | 1 | Nov 28, 2022 | sec.gov | |
| Mar 1, 2023 | New notice | $1,200,000 | $1,200,000 | 1 | Feb 28, 2023 | sec.gov | |
| May 27, 2021 | New notice | $40,000,000 | $20,000,000 | $20,000,000 | 1 | May 20, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas Jensen | Executive Officer, Director | |
| Gerald McLaughlin | Director | |
| Laura Benjamin | Director | |
| Joan Brown | Executive Officer | |
| Joseph Vazzano | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jan 29, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Allarity Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.